Rapibloc for Supraventricular tachycardia
Quick answer: Rapibloc is used for Supraventricular tachycardia as part of a beta-blocker (ultra-short-acting beta-1 selective) treatment regimen. Brand name for landiolol; ultra-short-acting selective beta-1 adrenergic receptor blocker reducing heart rate The specific dosing for Supraventricular tachycardia is determined by your prescriber based on individual factors.
Why is Rapibloc used for Supraventricular tachycardia?
Rapibloc belongs to the Beta-blocker (ultra-short-acting beta-1 selective) class. Brand name for landiolol; ultra-short-acting selective beta-1 adrenergic receptor blocker reducing heart rate This action makes it useful for treating or managing Supraventricular tachycardia in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Rapibloc is the right choice for a specific patient depends on the type and severity of Supraventricular tachycardia, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Supraventricular tachycardia
Common adult dosing range: 10-40 mcg/kg/min IV infusion. The actual dose for Supraventricular tachycardia depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Rapibloc medicine page.
What to expect
Rapibloc treatment for Supraventricular tachycardia typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Supraventricular tachycardia
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Rapibloc is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Beta-blocker (ultra-short-acting beta-1 selective) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Rapibloc
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Rapibloc full prescribing information · All Beta-blocker (ultra-short-acting beta-1 selective) alternatives
Frequently asked questions
How effective is Rapibloc for Supraventricular tachycardia?
Effectiveness varies by individual response, dose, and severity. Rapibloc is one of several treatment options for Supraventricular tachycardia, supported by clinical evidence within the beta-blocker (ultra-short-acting beta-1 selective) class. Discuss expected response with your prescriber.
How long do I need to take Rapibloc for Supraventricular tachycardia?
Treatment duration depends on the nature of Supraventricular tachycardia — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Rapibloc when used for Supraventricular tachycardia?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Rapibloc for Supraventricular tachycardia?
Yes. Multiple medicines and non-drug options exist for Supraventricular tachycardia. Alternatives within the beta-blocker (ultra-short-acting beta-1 selective) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.